Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26FT5FL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,875
Award facts
- Contract value 100% obligated
- $26,875.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of IMFINZI 500 mg/10 mL vials, valued at $26,875.44 with a firm fixed price structure. This is a non-set-aside, competitively awarded contract with performance completion targeted for January 30, 2026, to be fulfilled at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 31, 2031, serving as the overarching vehicle for pharmaceutical supply to military healthcare systems.
IMFINZI (durvalumab) is an oncology medication used in cancer treatment, reflecting the company's role as a critical supplier of specialized pharmaceutical products to federal military and veteran healthcare systems. AmerisourceBergen Drug Corp's selection for this delivery order demonstrates its established capability to supply brand-name medications across multiple therapeutic domains through open and competitive federal procurement processes. The firm fixed price structure and short completion timeline underscore the standard operational protocols for urgent pharmaceutical procurement within the Defense Logistics Agency's medical supply chain supporting the Defense Health Agency and other federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FT5FL?
SPE2DR26FT5FL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FT5FL worth?
The government has obligated $26,875 on SPE2DR26FT5FL.
Is contract SPE2DR26FT5FL an order under another contract?
Yes. SPE2DR26FT5FL is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT5FL competed?
The extent of competition for SPE2DR26FT5FL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award